Food-drug interactions

Oman Medical Journal

Volumn 26, Issue 2, 2011, Pages 77-83

  Bushra, Rabia ^a   Aslam, Nousheen ^a   Khan, Arshad Yar ^b  

^a ZIAUDDIN UNIVERSITY   (Pakistan)

^b UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Chelation; Cytochrome P450; Drug; Food drug interaction

Indexed keywords

EID: 84858425820     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2011.21     Document Type: Review

References (77)

1. Frankel EH. (2003). Basic Concepts. In: Hand book of food-drug Interactions, McCabe BJ, Frankel EH., Wolfe JJ (Eds.) pp. 2, CRC Press, Boca Raton, 2003.
2. Ayo JA, Agu H, Madaki I. Food and drug interactions: its side effects. Nutr Food Sci 2005;35(4):243-252
3. Schmidt LE, Dalhoff K. Food-drug interactions. Drugs 2002;62(10):1481-1502.
4. Nekvindová J, Anzenbacher P. Interactions of food and dietary supplements with drug metabolising cytochrome P450 enzymes. Ceska Slov Farm 2007 Jul;56(4):165-173.
5. Hansten PD. (2004) Appendix II: important interactions and their mechanisms, In: Katzung BG. (2004). editor, 09th edn, 2004) Basic and clinical Pharmacology, McGraw hill, Boston pp 1110.
6. Itagaki, S., Ochiai, A., Kobayashi, M., Sugawara, M., Hirano, T., Iseki, K.(2008). Interaction of Coenzyme Q10 with the Intestinal Drug Transporter P-Glycoprotein. J Agric Food Chem. 27; 56(16):6923-7.
7. Joshi R, Medhi B. Natural product and drugs interactions, its clinical implication in drug therapy management. Saudi Med J 2008 Mar;29(3):333-339.
8. Molden E, Spigset O. Fruit and berries-interactions with drugs. Tidsskr Nor Laegeforen 2007 Dec;127(24):3218-3220.
9. Kirby BJ, Unadkat JD. Grapefruit juice, a glass full of drug interactions? Clin Pharmacol Ther 2007 May;81(5):631-633.
10. Pawełczyk T, Kłoszewska I. Grapefruit juice interactions with psychotropic drugs: advantages and potential risk. Przegl Lek 2008;65(2):92-95.
11. de Castro WV, Mertens-Talcott S, Derendorf H, Butterweck V. Grapefruit juicedrug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells. J Pharm Sci 2007 Oct;96(10):2808-2817.
12. Genser D. Food and drug interaction: consequences for the nutrition/health status. Ann Nutr Metab 2008;52(Suppl 1):29-32.
13. Ellsworth AJ, Witt D, Dugdale D. (2000), Mosby's Medical drug reference, 1999-2000. Mosby and Co. Inc., St. Louis. pp 918-919
14. Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 2002 Jan;71(1):11-20.
15. Li P, Callery PS, Gan LS, Balani SK. Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction. Drug Metab Dispos 2007 Jul;35(7):1203-1208.
16. Li Y, Jiang X, Lan K, Zhang R, Li X, Jiang Q. Pharmacokinetic properties of rosuvastatin after single-dose, oral administration in Chinese volunteers: a randomized, open-label, three-way crossover study. Clin Ther 2007 Oct;29(10):2194-2203.
17. McCabe BJ, Frankel EH, Wolfe JJ. (2003). Monitoring nutritional status in drug regimens. In: Hand book of food-drug Interactions, McCabe BJ, Frankel EH., Wolfe JJ (Eds.). CRC Press, Boca Raton. pp 73-108
18. Vaquero MP, Sánchez Muniz FJ, Jiménez Redondo S, Prats Oliván P, Higueras FJ, Bastida S. Major diet-drug interactions affecting the kinetic characteristics and hypolipidaemic properties of statins. Nutr Hosp 2010 Mar-Apr;25(2):193-206.
19. Paeng CH, Sprague M, Jackevicius CA. Interaction between warfarin and cranberry juice. Clin Ther 2007 Aug;29(8):1730-1735.
20. Wittkowsky AK. Dietary supplements, herbs and oral anticoagulants: the nature of the evidence. J Thromb Thrombolysis 2008 Feb;25(1):72-77.
21. Hornsby LB, Hester EK, Donaldson AR. Potential interaction between warfarin and high dietary protein intake. Pharmacotherapy 2008 Apr;28(4):536-539.
22. Harris JE. Interaction of dietary factors with oral anticoagulants: review and applications. J Am Diet Assoc 1995 May;95(5):580-584.
23. Lacy CF, Armstrong LL, Goldman MP, Lance LL. (2005). Drug interaction handbooks. Laxicomp's Ohio. 13th edition. 706-708, 1269.
24. Holt GA. Food & Drug Interactions. Chicago. Precept Press 1998;1998:293.
25. Zikria J, Goldman R, Ansell J. Cranberry juice and warfarin: when bad publicity trumps science. Am J Med 2010 May;123(5):384-392.
26. Ansell J, McDonough M, Zhao Y, Harmatz JS, Greenblatt DJ. The absence of an interaction between warfarin and cranberry juice: a randomized, double-blind trial. J Clin Pharmacol 2009 Jul;49(7):824-830.
27. Griffiths AP, Beddall A, Pegler S. Fatal haemopericardium and gastrointestinal haemorrhage due to possible interaction of cranberry juice with warfarin. J R Soc Promot Health 2008 Nov;128(6):324-326.
28. Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006 Sep;26(9):1314-1319.
29. Grant P. Warfarin and cranberry juice: an interaction? J Heart Valve Dis 2004 Jan;13(1):25-26.
30. Pham DQ, Pham AQ (2007). Interaction potential between cranberry juice and warfarin. Am J Health Syst Pharm. 1;64(5):490-4.
31. Yamreudeewong W, Henann NE, Fazio A, Lower DL, Cassidy TG. Drug-food interactions in clinical practice. J Fam Pract 1995 Apr;40(4):376-384.
32. Walker SE, Shulman KI, Tailor SA, Gardner D. Tyramine content of previously restricted foods in monoamine oxidase inhibitor diets. J Clin Psychopharmacol 1996 Oct;16(5):383-388.
33. Volz HP, Gleiter CH. Monoamine oxidase inhibitors. A perspective on their use in the elderly. Drugs Aging 1998 Nov;13(5):341-355.
34. Sharma HL, Sharma KK. (2007) In: Principles of Pharmacology. Paras Medical Publisher, Hyderabad. pp 950.
35. Hyman Rapaport M. Translating the evidence on atypical depression into clinical practice. J Clin Psychiatry 2007;68(Suppl 3):31-36.
36. Bennett WM. Drug interactions and consequences of sodium restriction. Am J Clin Nutr 1997 Feb;65(2)(Suppl):678S-681S.
37. Uesawa Y, Mohri K. Hesperidin in orange juice reduces the absorption of celiprolol in rats. Int J Pharm 2008;355(1-2):93-99.
38. Ismail (2009). Drug-Food Interactions and Role of Pharmacist. Asian Journal of Pharmaceutical and Clinical Research, vol 2(4):1-10.
39. Størmer FC, Reistad R, Alexander J. Glycyrrhizic acid in liquorice-evaluation of health hazard. Food Chem Toxicol 1993 Apr;31(4):303-312.
40. Serra A, Uehlinger DE, Ferrari P, Dick B, Frey BM, Frey FJ, et al. Glycyrrhetinic acid decreases plasma potassium concentration in patients with anuria. G. Am. Soc. Nephrol. 2002;13:191-196.
41. Ploeger B, Mensinga T, Sips A, Seinen W, Meulenbelt J, DeJongh J. The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metab Rev 2001 May;33(2):125-147.
42. Størmer FC, Reistad R, Alexander J. Glycyrrhizic acid in liquorice-evaluation of health hazard. Food Chem Toxicol 1993 Apr;31(4):303-312.
43. Van H.K., Grundmeijer, H.G. (2007). Hypertension due to liquorice and liquorice tea consumption. Ned Tijdschr Geneeskd.; 22;151(51):2825-8.
44. Hodel M, Genné D. Rev Med Suisse. Antibiotics: drug and food interactions. 2009 Oct 7;5(220):1979-84.
45. McCabe BJ, Frankel EH, Wolfe JJ, eds. Hand book of food-drug Interactions (2003), CRC Press, Boca Raton, pp. 2.
46. Füredi P, Pápai K, Budai M, Ludányi K, Antal I, Klebovich I. In vivo effect of food on absorption of fluoroquinolones. Acta Pharm Hung 2009;79(2):81-87.
47. Pápai K, Budai M, Ludányi K, Antal I, Klebovich I. In vitro food-drug interaction study: Which milk component has a decreasing effect on the bioavailability of ciprofloxacin? J Pharm Biomed Anal 2010 May;52(1):37-42.
48. Akinleye MO, Coker HA, Chukwuani CM, Adeoye AW. Effect of Five Alive fruit juice on the dissolution and absorption profiles of ciprofloxacin. Nig Q J Hosp Med 2007 Jan-Mar;17(1):53-57.
49. Gurley BJ, Hagan DW. (2003). Herbal and dietary supplement interactions with drugs.In: Hand book of food-drug Interactions, McCabe BJ, Frankel EH., Wolfe JJ (Eds.), CRC Press, Boca Raton, 259-293.
50. Cardona Pera D. Drug-food interactions. Nutr Hosp 1999 May;14(Suppl 2):129S-140S.
51. Jung H, Peregrina AA, Rodriguez JM, Moreno-Esparza R. The influence of coffee with milk and tea with milk on the bioavailability of tetracycline. Biopharm Drug Dispos 1997 Jul;18(5):459-463.
52. Tanno FK, Sakuma S, Masaoka Y, Kataoka M, Kozaki T, Kamaguchi R, et al. Site-specific drug delivery to the middle-to-lower region of the small intestine reduces food-drug interactions that are responsible for low drug absorption in the fed state. J Pharm Sci 2008 Dec;97(12):5341-5353.
53. Miller B, Carthan N. (2003) Non-prescription drug and nutrient interaction. In: Hand book of food-drug Interactions, McCabe BJ, Frankel EH., Wolfe JJ (Eds.), CRC Press, Boca Raton, pp 251-258.
54. Kapil R, Nolting A, Roy P, Fiske W, Benedek I, Abramowitz W. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers. Clin Ther 2004 Dec;26(12):2015-2025.
55. Kondal A, Garg SK. Influence of acidic beverage (Coca-Cola) on pharmacokinetics of ibuprofen in healthy rabbits. Indian J Exp Biol 2003 Nov;41(11):1322-1324.
56. Scallion R, Moore KA. Effects of food intake on the pharmacokinetics of diclofenac potassium soft gelatin capsules: a single-dose, randomized, two-way crossover study. Clin Ther 2009 Oct;31(10):2233-2241.
57. Http://www.nclnet.org. Brochure (1989) Developed jointly by: American Pharmaceutical Association, Food and Drug Administration, Food Marketing Institute, National Consumers League. (Date of access, 6th August, 2008).
58. Sharif SI, Ali BH. Effect of grapefruit juice on drug metabolism in rats. Food Chem Toxicol 1994 Dec;32(12):1169-1171. PubMed doi:10.1016/0278-6915(94)90134-1
59. Gupta MC, Garg SK, Badyal D, Malhotra S, Bhargava VK. Effect of grapefruit juice on the pharmacokinetics of theophylline in healthy male volunteers. Methods Find Exp Clin Pharmacol 1999 Dec;21(10):679-682.
60. Katzung BG. (2004).Drugs with important actions on smooth muscle.In: Basic & Clinical Pharmacology. Katzung BG (Ed.) McGraw Hill, Boston, 9th Edn Pp. 259-269
61. Solans A, Carbó ML, Peña J, Nadal T, Izquierdo I, Merlos M. Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers: a single-dose, randomized, open-label, two-way crossover study. Clin Ther 2007 May;29(5):900-908.
62. Roe DA. (1991). Interactions of drugs with food and nutrients. In: Nutritional biochemistry and metabolism with clinical application, 2nd edition, Linder MC., Ed., Elsewier, New York, 1991, pp 559-571.
63. Roe DR. Nutrients and drug interactions. Nutr Rev 1994;42:141-154
64. Sostek MB, Chen Y, Andersson T. Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole. Br J Clin Pharmacol 2007 Sep;64(3):386-390.
65. Gardner DM, Shulman KI, Walker SE, Tailor SA. The making of a user friendly MAOI diet. J Clin Psychiatry 1996 Mar;57(3):99-104.
66. Self TH, Chrisman CR, Baciewicz AM, Bronze MS. Isoniazid drug and food interactions. Am J Med Sci 1999 May;317(5):304-311.
67. Ge F, Zeng F, Liu S, Guo N, Ye H, Song Y, et al. In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis. J Med Microbiol 2010 May;59(Pt 5):567-572.
68. Zhu M, Nix DE, Adam RD, Childs JM, Peloquin CA. Pharmacokinetics of cycloserine under fasting conditions and with high-fat meal, orange juice, and antacids. Pharmacotherapy 2001 Aug;21(8):891-897.
69. Rosskamp R, Wernicke-Panten K, Draeger E. Clinical profile of the novel sulphonylurea glimepiride. Diabetes Res Clin Pract 1996 Jul;31(Suppl):S33-S42.
70. Nolte MS, Karam JH. (2004). Pancreatic hormones and antidiabetic drugs. pp.693-707. In:katzung.
71. Centanni M, Franchi A, Santaguida MG, Virili C, Nardo S, Gargano L. Oral thyroxine treatment: towards an individually tailored dose. Recenti Prog Med 2007 Sep;98(9):445-451.
72. Lilja JJ, Laitinen K, Neuvonen PJ. Effects of grapefruit juice on the absorption of levothyroxine. Br J Clin Pharmacol 2005 Sep;60(3):337-341.
73. Tom-Revzon C, Adam HM. Drug interactions. Pediatr Rev 2006 Aug;27(8):315-317.
74. Lentz KA. Current methods for predicting human food effect. AAPS J 2008 Jun;10(2):282-288.
75. de Lemos ML, Hamata L, Jennings S, Leduc T. Interaction between mercaptopurine and milk. J Oncol Pharm Pract 2007 Dec;13(4):237-240.
76. Sacco SM, Chen J, Power KA, Ward WE, Thompson LU. Lignan-rich sesame seed negates the tumor-inhibitory effect of tamoxifen but maintains bone health in a postmenopausal athymic mouse model with estrogen-responsive breast tumors. Menopause 2008 Jan-Feb;15(1):171-179.
77. Xue H, Sawyer MB, Field CJ, Dieleman LA, Baracos VE. (2007). Nutritional modulation of antitumor efficacy and diarrhea toxicity related to irinotecan chemotherapy in rats bearing the ward colon tumor. Clin Cancer Res.; 1;13(23):7146-54.